More than two million people in the United States have a diagnosis of schizophrenia. For the last half century, the treatment for most has consisted mainly of antipsychotic medications that blunt hallucinations and delusions but which may also come with significant and unpleasant side effects. Recently, there has been remarkable new research in understanding and treating this debilitating mental illness.
In this program a neuropsychologist reports on new neurodevelopmental models of etiology and the many risk factors that can give rise to schizophrenia and to the psychosis-spectrum disorders. Next, the program director of one of the clinical sites used to study psychosis discusses how schizophrenia can be treated in its early stage. Following that, a psychiatrist explains how he applies self-psychology in his very close and connected treatment of early episode patients. Finally, the mother of a schizophrenic child discusses what the families of these patients need -- and don't receive.
Target audience: Psychologists, mental health counselors, marriage and family therapists, social workers, addiction counselors, nurses, case workers. This CE course is designated as intermediate. There is no known conflict of interest or commercial support.
You can access the audio to these interviews via your computer's MP3 player and/or read the text of the interviews.
Elaine Walker, PhD, is Samuel Candler Dobbs Professor of Psychology and Neuroscience in the Department of Psychology at Emory University. She leads a research laboratory that is funded by the National Institute of Mental Health to study risk factors for major mental illness. Her research is focused on child and adolescent development and the brain changes that are associated with adolescence. Recipient of many awards for her research, she has published over 200 scientific articles and six books dealing with mental health and neuroscience. Dr. Walker also teaches graduate and undergraduate courses at Emory.
Tia Dole, PhD, is the program director of the OnTrackNY Program at the Mental Health Association of Westchester, New York. Dr. Dole is a licensed clinical psychologist, and she holds a doctoral degree in clinical psychology from Fordham University, a master's degree in developmental psychopathology from Columbia University, and a bachelor's degree in psychology, secondary education, and French from Carleton College. Her specialties include early psychosis, personality disorders and trauma. Before coming to the Mental Health Association of Westchester, Dr. Dole was co-founder of the PEER Program at St. Luke's-Roosevelt Hospital, an early intervention program for first episode of psychosis.
David Garfield, MD, is Professor, Associate Chair for Psychotherapy and Director of the Psychiatry Residency Training Program at the Rosalind Franklin University of Medicine and Science, Chicago Medical School, which he has led since 1988. He graduated from the University of California, San Francisco School of Medicine and completed his psychiatry training at Harvard's Massachusetts Mental Health Center. He also finished his psychoanalytic training in 2006 at Chicago's Institute for Psychoanalysis, and he is on their voluntary teaching faculty. He has written dozens of articles on psychotherapy and his book, Unbearable Affect: A Guide to the Psychotherapy of Psychosis is in its second edition. With Dr. Ira Steinman, he has co-edited the book, Self Psychology and Psychosis, and he lectures internationally on psychosis. He serves the university as the chair of its Graduate Medical Education Committee.
Karen Mellow, JD, is a retired administrative law judge and parent of a schizophrenic child. She has advocated for and spoken frequently on behalf of the families of schizophrenic children.
At Health, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. At Health, LLC maintains responsibility for the program and its content.
At Health, LLC is an approved provider of continuing education through the co-sponsorship of At Health, LLC, and Amedco, LLC. Amedco, #1346, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education (ACE) program. Amedco maintains responsibility for the program. ASWB Approval Period: 6/24/2016 to 6/24/2019.
At Health, LLC is an approved provider of the Texas State Board of Social Work Examiners, provider #7414.
At Health, LLC is an approved provider of the Texas State Board of Examiners of Marriage and Family Therapists, provider #908.
These programs meet the criteria of an approved continuing education program for social work in Arkansas.
These programs meet the criteria of an approved continuing education program for social workers, professional counselors, marriage and family therapists, master's level psychologists, licensed clinical psychotherapists, and alcohol and other drug abuse counselors in Kansas.
These programs meet the criteria of an approved continuing education program for mental health practice and for social work in Nebraska.
These programs meet the criteria of an approved continuing education program for psychologists, pastoral psychotherapists, clinical social workers, clinical mental health counselors, marriage and family therapists, and alcohol and drug abuse counselors in New Hampshire.
These programs meet the criteria of an approved continuing education program for social workers, professional counselors, marital and family therapists, and clinical pastoral therapists in Tennessee.
Athealth.com is approved as a continuing education provider by the National Association of Alcoholism and Drug Abuse Counselors (NAADAC) Provider #148460.
The above CE sponsorships are honored by many additional state boards of social work, marriage and family therapy, and licensed professional counseling. Some restrictions may apply. Check with your state board or certifying organization to find out if online courses or home study are accepted as part of your continuing education requirement for license renewal or re-certification, or call At Health, LLC at 888-284-3258 for information regarding CE approvals.
Page last modified or reviewed by athealth.com on .
Upon completing this program, participants should be able to:
- Describe new models of the etiology of schizophrenia.
- Identify treatment methods that work best for schizophrenic patients.
- Discuss ways the therapist can make real connections with the patient.
- Help families gain access to resources at various stages of the patient's life.